Literature DB >> 10735342

Approach to the vaso-occlusive crisis in adults with sickle cell disease.

S H Yale1, N Nagib, T Guthrie.   

Abstract

The vaso-occlusive crisis, or sickle cell crisis, is a common painful complication of sickle cell disease in adolescents and adults. Acute episodes of severe pain (crises) are the primary reason that these patients seek medical care in hospital emergency departments. Frequently, however, the pain is incompletely treated. Despite advances in pain management, physicians are often reluctant to give patients adequate dosages of narcotic analgesics because of concerns about addiction, tolerance and side effects. It is important to recognize a pain crisis early, correct the inciting causes, control pain, maintain euvolemia and, when necessary, administer adequate hemoglobin to decrease the hemoglobin S level. The family physician and the hematologist must work together to treat acute pain episodes promptly and effectively, manage the long-term sequelae of chronic pain and prevent future vaso-occlusive crises.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735342

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  22 in total

1.  Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis.

Authors:  Mary P Borgerding; Randall K Absher; Tsz-Yin So
Journal:  World J Clin Pediatr       Date:  2013-11-08

2.  Sudden Death in Sickle Cell Anaemia: Report of Three Cases with Brief Review of Literature.

Authors:  Manickam Niraimathi; Rakhee Kar; Sajini Elizabeth Jacob; Debdatta Basu
Journal:  Indian J Hematol Blood Transfus       Date:  2015-07-22       Impact factor: 0.900

3.  The Use of Analgesic Drugs in Patients with Sickle Cell Painful Crisis.

Authors:  I Boyd; M Gossell-Williams; M G Lee
Journal:  West Indian Med J       Date:  2014-04-30       Impact factor: 0.171

4.  Health-related stigma in young adults with sickle cell disease.

Authors:  Coretta M Jenerette; Cheryl Brewer
Journal:  J Natl Med Assoc       Date:  2010-11       Impact factor: 1.798

5.  Eculizumab as a Treatment for Hyper-Haemolytic and Aplastic Crisis in Sickle Cell Disease.

Authors:  Ishan Patel; Mihir Odak; Steven Douedi; Abbas Alshami; Vandan D Upadhyaya; Mohammad Hossain; Madhurima Anne; Swapnil V Patel
Journal:  Eur J Case Rep Intern Med       Date:  2021-08-07

6.  Evaluation of Intravenous Diphenhydramine Use in Patients with Sickle Cell Vaso-Occlusive Crisis.

Authors:  Katherine Rector; Shelby Merchant; Rachel Crawford; Justin R Arnall; James Symanowski; Padmaja Veeramreddy; Ifeyinwa Osunkwo
Journal:  Hosp Pharm       Date:  2020-09-10

7.  Predictors of Academic Achievement for School Age Children with Sickle Cell Disease.

Authors:  Kelsey E Smith; Chavis A Patterson; Margo M Szabo; Reem A Tarazi; Lamia P Barakat
Journal:  Adv Sch Ment Health Promot       Date:  2013-01-25

8.  Care seeking for pain in young adults with sickle cell disease.

Authors:  Coretta M Jenerette; Cheryl A Brewer; Kenneth I Ataga
Journal:  Pain Manag Nurs       Date:  2013-01-21       Impact factor: 1.929

9.  Is MRI Necessary for Skeletal Evaluation in Sickle Cell Disease.

Authors:  Ankita Arun Sachan; Bhushan N Lakhkar; Bhavana B Lakhkar; Shivam Sachan
Journal:  J Clin Diagn Res       Date:  2015-06-01

Review 10.  Commonly used agent for acute pain management of sickle cell anemia in Saudi Emergency Department: A narrative review.

Authors:  Reem A Hejazi; Nameer A Mandourah; Aryaf S Alsulami; Hussain T Bakhsh; Reem M Diri; Ahmad O Noor
Journal:  Saudi Pharm J       Date:  2021-02-16       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.